Description
Phalanx Clomiphene is the backbone PCT compound — 50mg of Clomiphene Citrate, the selective oestrogen receptor modulator that has anchored post-cycle recovery protocols for decades. Clomiphene works by blocking oestrogen receptors at the hypothalamus and pituitary, removing the negative feedback that suppressive cycles impose on GnRH, LH, and FSH secretion. The result is a powerful endogenous testosterone stimulus: LH surges, FSH rises, and the testes begin producing testosterone again. At 50mg, this is the clinical PCT dose — effective, well-studied, and capable of driving testosterone recovery within weeks. Clomiphene’s two isomers (zuclomiphene and enclomiphene) both contribute: enclomiphene drives the HPG axis stimulation while zuclomiphene provides additional SERM activity. For full PCT, Clomiphene is typically stacked with Nolvadex (Tamoxifen) for complementary receptor modulation across different tissues. For fertility preservation and stimulation of spermatogenesis, Clomiphene has decades of clinical data. Verified at 99%+ purity by Puralytix. Standard PCT protocol: 50mg daily for weeks 1–2, 25mg daily for weeks 3–4, often alongside Nolvadex 20mg daily throughout. Bloodwork at 4 and 8 weeks post-cycle confirms testosterone recovery rate and guides protocol duration. Visual side effects (blurred vision, light sensitivity) are a known Clomiphene side effect due to zuclomiphene’s oestrogenic activity — discontinue if experienced.



Reviews
There are no reviews yet.